Paclitaxel

Overview

Paclitaxel is a chemotherapy drug used to treat various types of cancer, including ovarian, breast, and non-small cell lung cancer. It works by interfering with the normal function of microtubules during cell division.

API suppliers (34)

Suppliers of Paclitaxel backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• SCINOPHARM TAIWAN LTD2 active DMF
• SERIPHARM SAS1 active DMF
• TAPI NL BV1 active DMF
• SAMYANG HOLDINGS CORP1 active DMF
• YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD1 active DMF
• YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD1 active DMF
• TAPI NL BV1 active DMF
• TAPI NL BV1 active DMF
• SAMYANG HOLDINGS CORP1 active DMF
• TAPI NL BV1 active DMF
• YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD1 active DMF
• YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD1 active DMF
• YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD1 active DMF
• SERIPHARM SAS1 active DMF
• TAPI NL BV1 active DMF
• HAUSER CHEMICAL RESEARCH INC
• GREEN SPRINGS BIOCHEMISTRY
• PHYTOGEN LIFE SCIENCES INC
• INDENA SPAItaly
• CSF BIOTECH
• CHONGQING UNIT MODERN TECHNOLOGY CO LTD
• HUIANG BIO CHEMICAL PRODUCT MANUFACTURE COMPANY LTD
• CHROMADEX INC
• LD PHARMACEUTICAL
• BIOXEL PHARMA INC

Showing 25 of 34 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (16 approved US products), the latest listed US patent on Paclitaxel expires 11 Jul 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas